District of Columbia Healthcare Alliance Pharmacy and Therapeutics Committee

Description: There is hereby established in the Department of Health Care Finance (DHCF), the District of Columbia Healthcare Alliance Pharmacy and Therapeutics Committee (Committee).

The Committee shall, with the approval of the Director of DHCF, develop and maintain the District of Columbia Healthcare Alliance Drug Formulary for the District of Columbia Healthcare Alliance Program.  The Committee shall also recommend policies and best practice approaches that would help evaluate and select drugs of proven safety and therapeutic benefits and make them available to beneficiaries of the District of Columbia Healthcare Alliance Program.

Qualifications: The Committee shall be composed of the following twenty-one (21) members, who shall be appointed by the Director of DHCF:

a.      The Medical Director of DHCF, who shall serve as the chairperson of the Committee and shall be a non-voting member of the Committee; except that the Medical Director may vote when there is a tie vote among the voting members of the Committee;

b.     The DHCF Healthcare Delivery Management Administration (HCDMA) Director, who shall serve as the vice chairperson of the Committee and, in the absence of the Medical Director, shall serve as the chairperson of the Committee;

c.      Four (4) physicians practicing in the District of Columbia and providing services to District of Columbia Healthcare Alliance beneficiaries;

d.     Three (3) employees of the Department of Health Care Finance;

e.      The medical director and the pharmacy manager of each of the three (3) managed care organizations (MCOs) providing services to District of Columbia Healthcare Alliance beneficiaries.  The Director of DHCF, in appointing these members,  shall designate one (1) representative of each MCO as a voting member of the Committee and one (1) representative of each MCO as a non-voting member of the Committee;

f. Two (2) employees of the pharmacy benefit manager (PBM) that administers the prescription drug program for the DC Healthcare Alliance;

g. Two (2) employees of the Department of Health’s pealth Health   harmaceutical warehouse; and

h. Two (2) representatives from the District of Columbia Pharmacy Providers Network (DCPPN), both of whom shall serve as non-voting members of the Committee.

The Director of DHCF shall appoint the four (4) physician members of the Committee to serve for terms of three (3) years; The Director of DHCF shall appoint members to fill the remainder of unexpired terms as vacancies occur.  No physician member of the Committee shall be appointed for more than three (3) terms.

The other members of the Committee shall serve at the pleasure of the DHCF Director; provided, each such member shall serve only during his or her incumbency as an employee or representative of the agency or entity for which he or she was appointed.